Clinical trial
Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic…
NCT00420290 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00420290 |
|---|---|
| Title | Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients |
| Official title | Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | kineret, placebo |
| Enrollment | 31 |
| Start date | Jan 1, 2008 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Jan 11, 2007 |
| Last update posted | Nov 17, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: